“…While in incipient cancer innate and adaptive immune responses may clear some tumour cells (4), cancer-initiating cells (CiC) soon instruct infiltrating immune effector cells to adapt regulatory phenotypes (5). Such active immune suppression functions are accompanied by tumour-supported accumulation of Tregs, B cells, DCs, and M2 macrophages in its microenvironment, which may contribute immunoregulatory mediators such as IL-10 or VEGF, and B cells may express alternative Th2-biased IgG4 and IgA.…”